Experience

Pharmaseed Ltd

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Business Development Manager

  • Apr 2022 - Present



New Phase Ltd.

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Product Manager

  • Jan 2021 - Apr 2022

  Liaison between customers, KEEs, healthcare professionals, and company stakeholders. Product design and development, its adaptation to market requirements, usability studies, design verification, competitive analysis, and composition of regulatory documents. Clinical trial monitor.

• Researcher and Project lead

  • Dec 2019 - Jan 2021

  In-vitro and in-vivo research, stage I clinical trial monitor and project leader responsible for planning and preparation of key aspects in cancer treatment by magnetic hyperthermia.Publications:* Kraus S., Rabinovitz R. et al. (2022). Self-regulating novel iron oxide nanoparticle-based magnetic hyperthermia in swine: biocompatibility, biodistribution, and safety assessments. Archives of Toxicology. doi: 10.1007/s00204-022-03314-1* Rabinovitz R. et al. (2020). Novel Approach for Magnetic Nanoparticle-based Hyperthermia for Metastatic Cancer Treatment. BJSTR. MS.ID.005254.* Kraus, S. et al. (2021). Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model. Frontiers in oncology, 11, 761045. https://doi.org/10.3389/fonc.2021.761045 Show less



Israel Naval Medical Institute

• Research Assistant

  • Mar 2015 - Jul 2018

  Senior Academic Officer in the Israel Naval Medical Institute (INMI), part of “Atuda” military program. Senior Academic Officer in the Israel Naval Medical Institute (INMI), part of “Atuda” military program.



Technion - Israel Institute of Technology

• Israel
• Higher Education
• 700 & Above Employee

• Research Assistant

  • Jul 2015 - Jul 2016

  Research assistant at the laboratory of Dr. Ruth Perets of Women’s Cancer (Department of Medical Sciences). Studied the pharmacology of PARP-inhibitors on a transgenic mouse model of ovarian cancer. Research assistant at the laboratory of Dr. Ruth Perets of Women’s Cancer (Department of Medical Sciences). Studied the pharmacology of PARP-inhibitors on a transgenic mouse model of ovarian cancer.